CV Sciences, Inc. 8-K

What Happened
CV Sciences, Inc. (CVSI) filed a Current Report on Form 8‑K on March 26, 2026, reporting a Regulation FD disclosure and attaching a company press release dated March 26, 2026. The filing (Items 7.01 and 9.01) incorporates the Regulation FD Disclosure by reference and includes the press release as an exhibit. The report is signed by CEO Joseph Dowling.

Key Details

• Filing date: March 26, 2026 (Form 8‑K covering Regulation FD Disclosure under Item 7.01).
• Exhibit included: Press Release of CV Sciences, Inc. dated March 26, 2026 (listed under Item 9.01, Exhibit 99.1 or .1).
• Interactive data: Inline XBRL cover page (Exhibit 104) filed with the report.
• No earnings, financial results, mergers, or management changes are reported in this 8‑K.

Why It Matters
A Regulation FD disclosure indicates the company released information publicly to ensure fair and equal access for investors. While this 8‑K itself does not present earnings or executive changes, retail investors should read the attached March 26, 2026 press release for any material news (product updates, corporate developments, or forward guidance) that could affect CVSI’s stock. Monitor the company’s press release and subsequent SEC filings for any follow-up financial details or announcements.